| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > The Differences Between Line and Project Management |
|
Digg It - The Differences Between Line and Project Management
The first difference between these two is that line or middle management is mainly about operational and to According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product a lesser extent about tactical management.
Operational management is about managing daily activities. Tacti ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in al management is the “layer” between operational and strategic management; “How do we get there,” is one of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. he questions the tactical manager is dealing with. In that sense, the project manager of program manager fo here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe who manages various projects, is the tactical manager. He or she is concerned with the issue of transformin d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro the organization to its future form. The operational manager addresses most of its energy to directing peo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc le. Motivating, delegating, controlling, etc. in order to perform activities and gain results. On the short easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi erm the other resource categories are fixed. The project of program manager is concerned with planning. How nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically to prepare for the near future and reserve resources for doing this. One important issue that is just risin and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ between these two (operational and tactical) management areas; "should we close the shop during this period ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi " and "What will the client notice?" The dilemma is that in order to serve future clients you need to invest ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a and focus on the long term that might impact the current performance. Clients will notice this... Another dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod mportant issues between these two is that the operational management receives most of the information. Infor cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ation that is required for longer term projections and planning. But also information that is volatile.
In tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen mall business management these responsibility are combined in the role of operational management. The challe t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ge is the same; how do we focus on the longer term, not forgetting about the targets of this year. For both ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust situation the best solution is to plan: the budget for the current year should include the activities and in y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products estments that are for the longer term. The more you can plan for the near future, the more energy you save f . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r current business issues. In the mean time you should not forget that only the operational business define elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip the success for the future. Information about these two is like a critical success factor. © 2006 Hans Boo tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Socialists Say Entrepreneurs Only Care About Themselves as They Steal Profits From the Common Good
|